We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Piracetam injection is a sterile solution containing the active ingredient piracetam, which is a derivative of the neurotransmitter gamma-aminobutyric acid (GABA). Piracetam is classified as a nootropic or cognitive enhancer and is believed to modulate neurotransmission and improve cognitive function.
Indications:
Piracetam injection may be indicated for: Cognitive Enhancement: Piracetam is used to improve cognitive function, memory, and learning ability in individuals with cognitive impairment, age-related cognitive decline, or certain neurological conditions. Neuroprotection: Piracetam exhibits neuroprotective properties, potentially protecting neurons from damage caused by oxidative stress, ischemia, or other pathological processes. Treatment of Neurological Disorders: Piracetam injection may be used as adjunctive therapy in the management of various neurological disorders, including dementia, Alzheimer's disease, stroke, and traumatic brain injury.
Administration:
Piracetam injection is typically administered intravenously or intramuscularly under the supervision of a healthcare professional. The dosage and administration regimen may vary depending on the patient's condition, medical history, and the judgment of the prescribing physician.
Safety and Considerations:
As with any medication, piracetam injection should be used with caution and under the guidance of a qualified healthcare provider. Special consideration should be given to patients with renal impairment or other underlying medical conditions affecting drug metabolism..